Cannabicyclohexanol

From WikiMD's WELLNESSPEDIA

Structural isomers of Cannabicyclohexanol

Cannabicyclohexanol is a synthetic cannabinoid that has been used in the formulation of synthetic cannabis products. It is known for its potent psychoactive effects and has been a subject of interest in both medical and legal contexts.

Chemical Structure[edit]

Cannabicyclohexanol, also known as CP-47,497-C8, is a derivative of the compound CP-47,497. It is characterized by the addition of a cyclohexyl group to the structure, which significantly increases its affinity for the cannabinoid receptors in the brain. The chemical formula for Cannabicyclohexanol is C26H40O2.

Mechanism of Action[edit]

Cannabicyclohexanol acts as a full agonist at the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system. This system is involved in regulating various physiological processes including mood, memory, and pain sensation. The binding of Cannabicyclohexanol to these receptors mimics the effects of tetrahydrocannabinol (THC), the active component of cannabis.

Effects[edit]

The effects of Cannabicyclohexanol are similar to those of THC but are often more intense due to its higher potency. Users may experience euphoria, altered perception, and relaxation. However, adverse effects such as anxiety, paranoia, and tachycardia have also been reported.

Legal Status[edit]

Due to its potent effects and potential for abuse, Cannabicyclohexanol has been classified as a controlled substance in many countries. It is often included in the list of substances banned under synthetic cannabinoid regulations.

Health Implications[edit]

The use of Cannabicyclohexanol has been associated with several health risks. Acute intoxication can lead to severe psychological and physiological effects, and chronic use may result in dependency and withdrawal symptoms. The lack of regulation in synthetic cannabis products also poses a risk of contamination and inconsistent dosing.

Related Pages[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.